Several studies showed that patients with NAFLD have intrinsically higher C-reactive protein (CRP) and IL-6 serum concentrations, which are both associated with COVID-19 severity [13,14,15]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.